• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

5
results for

"Alzheimer Disease"

Filter

Article category

Keywords

Publication year

Authors

"Alzheimer Disease"

Review Article

Preventive Measures against the Development of Dementia in Old Age
Israel Oluwasegun Ayenigbara
Korean J Fam Med 2022;43(3):157-167.   Published online May 20, 2022
DOI: https://doi.org/10.4082/kjfm.21.0030
Dementia is a neurological condition characterized by numerous types of central nervous system diseases, which gradually deteriorates an individual’s reasoning, rational thinking, and judgment abilities. As a serious public health concern that currently affects more than 50 million older adults, dementia is one of the most significant causes of incapacity, disability, and dependency among older adults. As new cases are expected to increase exponentially in the next three decades, dementia, which is not a normal feature of healthy aging despite the fact that it generally affects older adults disproportionately, requires enormous management and care efforts due to its associated socioeconomic, psychological, and physical burdens that involve the patient, their caregivers, guardians, family members, and society at large. Presently, there is no cure for dementia; however, this condition could be prevented. This narrative review aimed to provide a broad overview of studies detailing the alternative lifestyle modification-centered preventive measures against dementia. A comprehensive search of key databases to find articles related to this topic revealed that participating in regular physical activities, healthy eating and dieting, avoiding all forms of smoking, avoiding air pollutants, halting or reducing alcohol consumption, exercising the mind and being socially dynamic, getting enough rest and establishing good sleeping habits, infection prevention, stress prevention, avoidance of injuries, preventing the effects of social isolation and lockdowns, continuing education, and depression prevention are protective measures against the development of dementia.

Citations

Citations to this article as recorded by  
  • Protective effect of adult vaccination on the development of dementias: A systematic review
    E. Mariscal-Lopez, M. Agredano-Sanchez, R.M. Lopez-Gigosos, A. Mariscal, F. Fariñas-Guerrero, M. Gutierrez-Bedmar, M. Guts-Chornoknyzha
    Neurología.2026; 41(2): 501939.     CrossRef
  • Protective effect of adult vaccination on the development of dementias: A systematic review
    E. Mariscal-Lopez, M. Agredano-Sanchez, R.M. Lopez-Gigosos, A. Mariscal, F. Fariñas-Guerrero, M. Gutierrez-Bedmar, M. Guts-Chornoknyzha
    Neurología (English Edition).2026; 41(2): 501939.     CrossRef
  • Reclaiming wellness: Key factors in restoring optimal well-being in the Canadian Longitudinal Study on Aging
    Mabel Ho, Esme Fuller-Thomson, Isaac Akintoyese Oyekola
    PLOS One.2025; 20(9): e0329800.     CrossRef
  • Guidelines for nutrition counseling in primary healthcare clinics
    Gyeongsil Lee, Seung-Won Oh
    Journal of the Korean Medical Association.2024; 67(4): 278.     CrossRef
  • A Genome-Wide Association Study of Dementia Using the Electronic Medical Record
    Xiaowen Cao, Yao Dong, Li Xing, Xuekui Zhang
    BioMedInformatics.2023; 3(1): 141.     CrossRef
  • Health promotion: the essence of primary healthcare
    Sung Sunwoo
    Journal of the Korean Medical Association.2022; 65(12): 772.     CrossRef
  • 9,905 View
  • 143 Download
  • 5 Web of Science
  • 6 Crossref

Original Articles

Medial Temporal Atrophy Alone is Insufficient to Predict Underlying Alzheimer’s Disease Pathology
Hyo Eun Jeong, Da Hye Shin, Duk-Chul Lee
Korean J Fam Med 2020;41(5):352-358.   Published online June 11, 2020
DOI: https://doi.org/10.4082/kjfm.18.0144
Background
The medial temporal region is the earliest affected structure in patients with Alzheimer’s disease (AD), and its atrophy is known as the hallmark of AD. This study aimed to investigate the value of medial temporal atrophy (MTA) for detecting 18F-florbetaben positron emission tomography (PET)-proven AD pathology.
Methods
We retrospectively enrolled 265 subjects complaining of cognitive decline at a dementia outpatient clinic from March 2015 to December 2017. All subjects underwent brain magnetic resonance imaging, 18F-fluorodeoxyglucose PET, and 18F-florbetaben PET at baseline. We performed multivariable logistic regression analyses on variables including age, sex, years of education, white matter hyperintensities, apolipoprotein E (APOE) genotype, and memory composite scores in various combinations to investigate whether MTA was indicative of underlying AD pathology.
Results
Our sample population of 265 patients comprised 121 with AD-related cognitive impairment, 42 with Lewy bodies-related cognitive impairment, 32 with vascular cognitive impairment, and 70 with other or undetermined pathologies. In the multivariable logistic regression analyses, MTA was not an independent predictor of underlying AD pathology (P>0.200). The predictive power of underlying AD-related cognitive impairment significantly increased when multiple variables including APOE genotype and memory composite scores were considered together (area under the curve >0.750).
Conclusion
Our results suggest that MTA alone may be insufficient to accurately predict the presence of AD pathology. It is necessary to comprehensively consider various other factors such as APOE genotype and a detailed memory function to determine whether the patient is at high risk of AD.

Citations

Citations to this article as recorded by  
  • Brain MRI volumetry and atrophy rating scales as predictors of amyloid status and eligibility for anti-amyloid treatment in a real-world memory clinic setting
    A. Zilioli, A. Rosenberg, R. Mohanty, A. Matton, T. Granberg, G. Hagman, J. Lötjönen, M. Kivipelto, E. Westman
    Journal of Neurology.2025;[Epub]     CrossRef
  • CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome
    Durjoy Lahiri, Bruna Seixas-Lima, Carlos Roncero, Nicolaas Paul Verhoeff, Morris Freedman, Sarmad Al-Shamaa, Howard Chertkow
    Frontiers in Neurology.2024;[Epub]     CrossRef
  • White matter hyperintensities in cholinergic pathways are associated with dementia severity in e4 carriers but not in non-carriers
    Ming-Chun Yu, Yi-Fang Chuang, Shu-Ching Wu, Cheng-Feng Ho, Yi-Chien Liu, Chia-Ju Chou
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Brain atrophy pattern in patients with mild cognitive impairment: MRI study
    Rosalinda Calandrelli, Marco Panfili, Valeria Onofrj, Huong Elena Tran, Francesca Piludu, Valeria Guglielmi, Cesare Colosimo, Fabio Pilato
    Translational Neuroscience.2022; 13(1): 335.     CrossRef
  • 7,067 View
  • 75 Download
  • 5 Web of Science
  • 4 Crossref
Survival Analysis of Patients with Alzheimer’s Disease: A Study Based on Data from the Korean National Health Insurance Services’ Senior Cohort Database
Tae Ho Huh, Jong Lull Yoon, Jung Jin Cho, Mee Young Kim, Young Soo Ju
Korean J Fam Med 2020;41(4):214-221.   Published online April 23, 2020
DOI: https://doi.org/10.4082/kjfm.18.0114
Background
Korea’s rapidly aging population has experienced a sharp rise in the prevalence of dementia. Patients with Alzheimer’s disease (AD), which is estimated to be about three-quarters of all patients with dementia, tend to have higher mortality rates compared with patients without Alzheimer’s disease. In this study, a survival analysis of patients with AD was conducted in order to provide knowledge to those who provide medical care to these patients.
Methods
Data on individuals over 65 years old in 2004 were extracted from the Korean National Health Insurance Services’ Senior Cohort database (2002–2013). The subjects were 209,254 patients, including 2,695 who were first diagnosed with AD (the AD group) and 206,559 that had not been diagnosed with the disease (non-AD group). To investigate the independent effect of AD on survival, the Cox proportional-hazards model, hazard ratios (confidence interval of 95%), and the Kaplan-Meier method were used.
Results
Mean survival time in the AD group was 5.3±3.3 years, which was about 2.5 years shorter than that in the non-AD group (7.8±2.4 years). The mortality rate in the AD group (66.3%) was higher than that in the non-AD group (26.3%). The adjusted hazard ratio in the AD group was 2.5 and, therefore, it was found that the AD group had a 2.5-fold higher risk of death than the non-AD group.
Conclusion
Overall, AD has a large, independent impact on survival. Survival time was shorter, and the mortality rate and risk were generally higher in the AD group, compared with the non-AD group.

Citations

Citations to this article as recorded by  
  • Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review
    Purnima Rani Debi, Hrishika Barua, Mirja Kaizer Ahmmed, Shuva Bhowmik
    Marine Drugs.2025; 23(8): 310.     CrossRef
  • Clinical profile and survival analysis of Alzheimer’s disease patients in a Brazilian cohort
    Elisa de Melo Queiroz, Christian Marques Couto, Cláudio Antônio da Cruz Mecone, Waneska Souza Lima Macedo, Paulo Caramelli
    Neurological Sciences.2024; 45(1): 129.     CrossRef
  • Survival After the Diagnosis of Mild‐to‐Moderate Alzheimer's Disease Dementia: A 15‐Year National Cohort Study in Taiwan
    Yu Sun, Chih‐Ching Liu, Chung‐Yi Li, Ming‐Jang Chiu
    International Journal of Geriatric Psychiatry.2024;[Epub]     CrossRef
  • Collaborative Survival Analysis on Predicting Alzheimer’s Disease Progression
    Wanwan Xu, Selena Wang, Li Shen, Yize Zhao
    Statistics in Biosciences.2024;[Epub]     CrossRef
  • Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance
    Khanh Linh Duong, Heeyoon Jung, Hyun-kyoung Lee, Young Jin Moon, Sang Ki Lee, Bo Ram Yang, Hwi-yeol Yun, Jung-woo Chae
    BMC Geriatrics.2024;[Epub]     CrossRef
  • Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES
    Rei Ono, Takashi Sakurai, Taiki Sugimoto, Kazuaki Uchida, Takeshi Nakagawa, Taiji Noguchi, Ayane Komatsu, Hidenori Arai, Tami Saito
    Journal of Alzheimer's Disease.2023; 92(2): 487.     CrossRef
  • Infections among individuals with multiple sclerosis, Alzheimer’s disease and Parkinson’s disease
    Yihan Hu, Kejia Hu, Huan Song, Yudi Pawitan, Fredrik Piehl, Fang Fang
    Brain Communications.2023;[Epub]     CrossRef
  • Independent effects of amyloid and vascular markers on long‐term functional outcomes: An 8‐year longitudinal study of subcortical vascular cognitive impairment
    Sung Hoon Kang, Sook‐young Woo, Seonwoo Kim, Jun Pyo Kim, Hyemin Jang, Seong‐Beom Koh, Duk L. Na, Hee Jin Kim, Sang Won Seo
    European Journal of Neurology.2022; 29(2): 413.     CrossRef
  • Deep learning algorithm reveals probabilities of stage‐specific time to conversion in individuals with neurodegenerative disease LATE
    Xinxing Wu, Chong Peng, Peter T. Nelson, Qiang Cheng
    Alzheimer's & Dementia: Translational Research & Clinical Interventions.2022;[Epub]     CrossRef
  • Time‐to‐event prediction using survival analysis methods for Alzheimer's disease progression
    Rahul Sharma, Harsh Anand, Youakim Badr, Robin G. Qiu
    Alzheimer's & Dementia: Translational Research & Clinical Interventions.2021;[Epub]     CrossRef
  • 7,646 View
  • 147 Download
  • 10 Web of Science
  • 10 Crossref
Risk Factors of Behavioral and Psychological Symptoms in Patients with Alzheimer Disease: The Clinical Research of Dementia of South Korea Study
Sunyoung Park, Doh Kwan Kim, Woojae Myung, Jun Hyun Yoo, Su Jeong Shin, Duk L. Na, Sang Yun Kim, Jae-Hong Lee, Seong Yoon Kim, Seol-Heui Han, Seong Hye Choi, Jinyoung Shin
Korean J Fam Med 2019;40(1):16-21.   Published online October 29, 2018
DOI: https://doi.org/10.4082/kjfm.17.0061
Background
Few studies have evaluated risk factors for behavioral and psychological symptoms of dementia at the initial assessment for Alzheimer disease in large patient samples. In this study, the factors influencing Alzheimer disease were examined using the Clinical Research of Dementia of South Korea data.
Methods
This cross-sectional study was conducted using data of 1,128 patients with Alzheimer disease. The behavioral and psychological symptoms of dementia were examined using the Korean version of the Neuropsychiatric Inventory. Demographic characteristics, health-related behavior, neuropsychological tests, comorbidities, blood test results, and caregiver characteristics were assessed. Median logistic regression analysis with adjustment for covariates was conducted.
Results
The behavioral and psychological symptoms of dementia were negatively associated with memory (P=0.022) and frontal/executive (P<0.001) function in the Seoul Neuropsychological Screening Battery-dementia, Barthel Index for Activities of Daily Living (P<0.001), Korean version of the Mini-Mental State Examination score (P=0.003), and caregiver age (P=0.005) after adjustment for confounding factors, and positively associated with the Seoul-Instrumental Activities of Daily Living score (P<0.001), Clinical Dementia Rating Sum of Box (P<0.001), Global Deterioration Scale score (P<0.001), abnormality of free T4 level (P<0.001), anemia (P<0.001), and family history of stroke (P=0.001). Patients with female caregivers exhibited more severe behavioral and psychological symptoms of dementia than those with male caregivers.
Conclusion
Behavioral and psychological symptoms of dementia in Alzheimer disease patients were associated with various risk factors including the inability to live independently and Alzheimer disease severity. These findings suggest that prevention and treatment strategies for the behavioral and psychological symptoms of dementia should be comprehensive.

Citations

Citations to this article as recorded by  
  • A retrospective study on blood microbiota as a marker for cognitive decline: implications for detecting Alzheimer’s disease and amnestic mild cognitive impairment in Republic of Korea
    Youngchan Park, Jong-Young Lee, Eek-Sung Lee
    Osong Public Health and Research Perspectives.2025; 16(2): 141.     CrossRef
  • The impact of lifetime excessive alcohol use on behavioural and psychological symptoms of dementia
    Emytis Tavakoli, Elaina Niciforos, Parmida Amid, Ari B Cuperfain, Amer M Burhan, Sarah Colman, Li Chu, Simon J C Davies, Peter Derkach, Philip Gerretsen, Ariel Graff-Guerrero, Maria Hussain, Zahinoor Ismail, Donna Kim, Linda Krisman, Benoit H Mulsant, Bru
    Alcohol and Alcoholism.2025;[Epub]     CrossRef
  • The Associations Between Neuropsychiatric Symptoms and Cognition in People with Dementia: A Systematic Review and Meta-Analysis
    Julieta Sabates, Wei-Hsuan Chiu, Samantha Loi, Amit Lampit, Hanna M. Gavelin, Terence Chong, Nathalie Launder, Anita M. Y. Goh, Amy Brodtmann, Nicola Lautenschlager, Alex Bahar-Fuchs
    Neuropsychology Review.2024; 34(2): 581.     CrossRef
  • Development of the Dardashna Checklist for Identifying Triggers of Behavioral Change in Individuals With Dementia: A Qualitative Study
    Parastoo Amiri, Mehdi Samadani, Parviz Rashidi Khazaee, Kambiz Bahaadinbeigy
    Journal of Gerontological Nursing.2024; 50(1): 37.     CrossRef
  • Prevalence of behavioral risk factors and their association with dementia in the urban population of North India
    Ram B Singh, Agnieszka Wilczynska, Jan Fedacko, Rie Horiuchi, Toru Takahashi, Ghizal Fatima, MA Manal Ismail, Aminat Magomedova
    MOJ Public Health.2023; 12(1): 46.     CrossRef
  • Case Management-based Collaborative Care Model Associated with improvement in neuropsychiatric outcomes in community-dwelling people living with dementia
    Yu-Hsuan Hung, Wen-Fu Wang, Ming-Che Chang, Kai-Ming Jhang
    BMC Geriatrics.2023;[Epub]     CrossRef
  • Risk, Resilience, and the Two-Track Model of Dementia Grief Among Spouses of People Living With Cognitive Decline
    Alexander Manevich, Simon Shimshon Rubin, Michael Katz, Rachel Ben-Hayun, Judith Aharon-Peretz
    Gerontology and Geriatric Medicine.2023;[Epub]     CrossRef
  • The effects of caregiver characteristics on behavioral and psychological symptoms of dementia of patients with dementia
    Pei-Chao Lin, Hui-Tzu Lin, Yu-Hsiang Yang, Yuan-Han Yang
    Aging & Mental Health.2022; 26(2): 263.     CrossRef
  • Red Cell Distribution Width, Anemia, and Brain Volumetric Outcomes Among Middle-Aged Adults
    May A. Beydoun, Sharmin Hossain, Peter H. MacIver, Dhivya Srinivasan, Hind A. Beydoun, Ana I. Maldonado, Leslie I. Katzel, Christos Davatzikos, Rao P. Gullapalli, Stephen L. Seliger, Guray Erus, Michele K. Evans, Alan B. Zonderman, Shari R. Waldstein
    Journal of Alzheimer's Disease.2021; 81(2): 711.     CrossRef
  • Red cell distribution width, anemia and their associations with white matter integrity among middle-aged urban adults
    May A. Beydoun, Danielle Shaked, Sharmin Hossain, Jordan Weiss, Hind A. Beydoun, Ana I. Maldonado, Leslie I. Katzel, Christos Davatzikos, Rao P. Gullapalli, Stephen L. Seliger, Guray Erus, Michele K. Evans, Alan B. Zonderman, Shari R. Waldstein
    Neurobiology of Aging.2021; 105: 229.     CrossRef
  • The complex conundrum of geriatric depression and dementias
    Sanchari Mukhopadhyay, Debanjan Banerjee
    Journal of Geriatric Mental Health.2021; 8(2): 93.     CrossRef
  • Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review
    Federica Vinciguerra, Marco Graziano, Maria Hagnäs, Lucia Frittitta, Andrea Tumminia
    Nutrients.2020; 12(4): 1019.     CrossRef
  • Relationship between Performance on the Mini-Mental State Examination Sub-Items and Activities of Daily Living in Patients with Alzheimer’s Disease
    Gwanghee Han, Michio Maruta, Yuriko Ikeda, Tomohisa Ishikawa, Hibiki Tanaka, Asuka Koyama, Ryuji Fukuhara, Shuken Boku, Minoru Takebayashi, Takayuki Tabira
    Journal of Clinical Medicine.2020; 9(5): 1537.     CrossRef
  • Association of Antioxidant Vitamins A, C, E and Carotenoids with Cognitive Performance over Time: A Cohort Study of Middle-Aged Adults
    May A. Beydoun, Jose A. Canas, Marie T. Fanelli-Kuczmarski, Ana I. Maldonado, Danielle Shaked, Mika Kivimaki, Michele K. Evans, Alan B. Zonderman
    Nutrients.2020; 12(11): 3558.     CrossRef
  • 12,109 View
  • 168 Download
  • 14 Web of Science
  • 14 Crossref
Review Article
Is It Possible to Delay or Prevent Age-Related Cognitive Decline?
Jean-Pierre Michel
Korean J Fam Med 2016;37(5):263-266.   Published online September 21, 2016
DOI: https://doi.org/10.4082/kjfm.2016.37.5.263

Already in the 90s, Khachaturian stated that postponing dementia onset by five years would decrease the prevalence of the late onset dementia by 50%. After two decades of lack of success in dementia drug discovery and development, and knowing that worldwide, currently 36 million patients have been diagnosed with Alzheimer's disease, a number that will double by 2030 and triple by 2050, the World Health Organization and the Alzheimer's Disease International declared that prevention of cognitive decline was a 'public health priority.' Numerous longitudinal studies and meta-analyses were conducted to analyze the risk and protective factors for dementia. Among the 93 identified risk factors, seven major modifiable ones should be considered: low education, sedentary lifestyle, midlife obesity, midlife smoking, hypertension, diabetes, and midlife depression. Three other important modifiable risk factors should also be added to this list: midlife hypercholesterolemia, late life atrial fibrillation, and chronic kidney disease. After their identification, numerous authors attempted to establish dementia risk scores; however, the proposed values were not convincing. Identifying the possible interventions, able to either postpone or delay dementia has been an important challenge. Observational studies focused on a single life-style intervention increased the global optimism concerning these possibilities. However, a recent extensive literature review of the randomized control trials (RCTs) conducted before 2014 yielded negative results. The first results of RCTs of multimodal interventions (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Multidomain Alzheimer Prevention Study, and Prediva) brought more optimism. Lastly, interventions targeting compounds of beta amyloid started in 2012 and no results have yet been published.

Citations

Citations to this article as recorded by  
  • ReCOGnAIze app to detect vascular cognitive impairment and mild cognitive impairment
    Adnan Azam Mohammed, Ashwati Vipin, Yi Jin Leow, Eliana Setiabudi, Farid Tan, Hitesh Agarwal, Kai Xin Liau, Pricilia Tanoto, Shan Yao Liew, Bocheng Qiu, Gurveen Kaur Sandhu, Jia Dong James Wang, Kiirtaara Aravindhan, Nagaendran Kandiah
    Alzheimer's & Dementia.2026;[Epub]     CrossRef
  • The relationship between traditional risk factors for vascular cognitive impairment and the development of cephalgic syndrome, and the impact of headache on patients' daily life activity
    Viktoriia A. Vershuta, Olga N. Voskresenskaya, Gyuzyal R. Tabeeva
    Consilium Medicum.2025; 27(11): 646.     CrossRef
  • Examining biopsychosocial predictors of risk for cognitive impairment among a racially diverse sample of men who have sex with men living with HIV
    Casey D. Xavier Hall, Beth Okantey, Zhuo Meng, Crim Sabuncu, Brittany Lane, Eugenia Millender, Artur Queiroz, Jung Hyo Kim, Lorie Okada, Avrum Gillespie, Gina Simoncini, John ‘Jack’ P. Barile, Grace X. Ma, Frank ‘Frankie’ Y. Wong
    Therapeutic Advances in Infectious Disease.2024;[Epub]     CrossRef
  • Trajectory classes of social activity and their effects on longitudinal changes in cognitive function among older adults
    Da Eun Kim, Ju Young Yoon
    Archives of Gerontology and Geriatrics.2022; 98: 104532.     CrossRef
  • Swertiamarin ameliorates inflammation and oxidative damage in autoimmune encephalomyelitis mouse model
    Hairul-Islam Mohamed Ibrahim, Emad A. Ahmed, Abdullah M. Alzahrani, Abdullah A. Sayed, Hamza Hanieh
    Applied Biological Chemistry.2022;[Epub]     CrossRef
  • The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment
    V. A. Golovacheva
    Neurology, Neuropsychiatry, Psychosomatics.2020; 12(2): 119.     CrossRef
  • Long-Term Intake of Dietary Carotenoids Is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women
    Changzheng Yuan, Elinor Fondell, Alberto Ascherio, Olivia I Okereke, Francine Grodstein, Albert Hofman, Walter C Willett
    The Journal of Nutrition.2020; 150(7): 1871.     CrossRef
  • Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders
    Andrea Rodrigues Vasconcelos, Nilton Barreto dos Santos, Cristoforo Scavone, Carolina Demarchi Munhoz
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Multidomain Lifestyle Intervention Strategies for the Delay of Cognitive Impairment in Healthy Aging
    Josef Toman, Blanka Klímová, Martin Vališ
    Nutrients.2018; 10(10): 1560.     CrossRef
  • The impact of obesity on neurodegenerative diseases
    Janaína Niero Mazon, Aline Haas de Mello, Gabriela Kozuchovski Ferreira, Gislaine Tezza Rezin
    Life Sciences.2017; 182: 22.     CrossRef
  • Impact of diet-derived signaling molecules on human cognition: exploring the food–brain axis
    Raymond L. Rodriguez, John G. Albeck, Ameer Y. Taha, Kassandra M. Ori-McKenney, Gregg H. Recanzone, Tyler W. Stradleigh, Bronte C. Hernandez, Feng-Yao Vincent Tang, En-Pei Isabel Chiang, Lillian Cruz-Orengo
    npj Science of Food.2017;[Epub]     CrossRef
  • The Feasibility and Necessity of a Revolution in Geriatric Medicine
    Giacinto Libertini
    OBM Geriatrics.2017; 01(02): 1.     CrossRef
  • 7,862 View
  • 66 Download
  • 10 Web of Science
  • 12 Crossref
TOP